COVID-19 severity has been associated to an extrafollicular B-cell activation, reduced cTfh, robust Tbet+ PB response and early production of high levels of SARS-CoV-2 specific neutralising Abs6,38,39, suggesting a T-cell independent B-cell response. The gene discussed is TBX21; the disease is COVID-19.